Retrospective Chart Review of Candida Fungemia
NCT03827330 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2020-11-27
Summary
Background:
Candida can cause infections. The most common kind of Candida at clinics is C albicans. But other kinds have increased at clinics too. Researchers want to review the records of people who were in previous NIH studies who had Candida. They want to find out what risk factors are associaated with this infection.
Objective:
To study the factors that are associated with Candida fungemia to develop. The factors are clinical features, diagnoses, and previous antifungal therapy.
Eligibility:
People who were in prior NIH studies and had Candida
Design:
Researchers will review the records of 62 NIH participants. The records are from 2004 to 2017. They will look at data such as blood test results, diagnosis, and treatments.
Researchers will only reach out to participants if they get approval from a review board.
This research will probably not reveal data that would be important to participants health. But if it does, researchers will try to contact those participants.
Data will be stored in secure computers. They will be stored with a code that only the study team can link to a participant.
Conditions
- Candida Fungemia
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Michail S Lionakis, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-03
- Primary Completion
- 2020-11-18
- Completion
- 2020-11-18
Countries
- United States
Study Locations
More Related Trials
-
Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility
NCT01077336 ·Status: COMPLETED
-
Anidulafungin Versus Fluconazole in the Treatment of Candidemia
NCT00058682 ·Status: COMPLETED ·Phase: PHASE3
-
A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)
NCT01174147 ·Status: COMPLETED
-
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
NCT00002325 ·Status: COMPLETED ·Phase: NA
-
Prevalence and Epidemiology of Nosocomial Candidaemia and Antifungal Susceptibility Patterns in an Italian Tertiary-Care Hospital
NCT00903526 ·Status: UNKNOWN
-
Early- and Late-onset Candidemia
NCT01406093 ·Status: COMPLETED
-
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
NCT00445952 ·Status: COMPLETED
-
A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections
NCT00002277 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
NCT00002339 ·Status: COMPLETED ·Phase: PHASE3
-
Candidemia in a Pediatric Center and Importance of Central Venous Catheter Removal
NCT02088476 ·Status: COMPLETED
-
A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
NCT00002304 ·Status: COMPLETED ·Phase: NA
-
Efflux Pump Mediated Azole Resistance in Candida Albicans
NCT03659162 ·Status: UNKNOWN
-
The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis
NCT05235711 ·Status: COMPLETED
-
Research of New Serological Markers for the Diagnosis and Monitoring of Candidaemia in Hospitalized Patients
NCT05720728 ·Status: COMPLETED
-
Natural History of Individuals With Immune System Problems That Lead to Fungal Infections
NCT01386437 ·Status: RECRUITING
-
A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
NCT01982071 ·Status: TERMINATED ·Phase: PHASE4
-
Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis
NCT00004938 ·Status: COMPLETED ·Phase: PHASE2
-
Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia
NCT00189709 ·Status: COMPLETED ·Phase: PHASE3
-
Immunological Interaction Between the Host and Candida Albicans Biofilm
NCT01919931 ·Status: COMPLETED
-
Biofilm Formation and Antifungal Resistance in Candida Species
NCT07245563 ·Status: NOT_YET_RECRUITING
-
Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS
NCT00001017 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Micafungin in Patients With Invasive Candidiasis or Candidemia
NCT00105144 ·Status: COMPLETED ·Phase: PHASE3
-
A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections
NCT02678598 ·Status: COMPLETED
-
Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study)
NCT01752166 ·Status: COMPLETED
-
SIHAM Candidemia Network:An Observational Study
NCT01281345 ·Status: COMPLETED